Interim results from an open-label, single-center, hybrid-virtual 12-month trial of a Lunasin regimen for patients with Amyotrophic Lateral Sclerosis

F1000Research(2016)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要